Kiniksa Pharmaceuticals’ (KNSA) Outperform Rating Reiterated at Wedbush
Kiniksa Pharmaceuticals (NASDAQ:KNSA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Wedbush in a report issued on Tuesday,RTT News reports. They currently have a $34.00 target price on the stock. Wedbush’s price target points to a potential upside of 72.68% from the company’s current price. A number of […]
Kiniksa Pharmaceuticals (NASDAQ:KNSA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Wedbush in a report issued on Tuesday,RTT News reports. They currently have a $34.00 target price on the stock. Wedbush’s price target points to a potential upside of 72.68% from the company’s current price. A number of […]
